REPORTS

Let’s Pullulate and Expand Your Business

Global Influenza Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 10, 2020  |  228 PAGES  |  REPORT CODE: CMM337611
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Influenza Vaccine is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period. The research provides insights for the global Influenza Vaccine market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Influenza Vaccine industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Influenza Vaccine Market Segmentations:

By Players:

  • AstraZeneca

  • CSL

  • GlaxoSmithKline

  • Sanofi

  • Altimmune

  • BionVax

  • FluGen

  • Folia Biotech

  • Genentech

  • Green Cross

  • Medicago

  • Moderna Therapeutics

  • Novavax

  • Shijiazhuang Yiling Pharmaceutical

  • SK Chemicals

  • UNM Pharma

  • Vaccitec

By Types:

  • Fluzone/Vaxigrip

  • FluMist

  • Fluarix and Flulaval

  • Anflu

  • Fluvax/Afluria

  • Flucelvax and Fluvirin

By End-User:

  • Flucelvax and Fluvirin

  • Flucelvax and Fluvirin

  • Flucelvax and Fluvirin

  • Flucelvax and Fluvirin

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccine Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip from 2014 to 2026

    • 1.3.2 Global Influenza Vaccine Market Size and Growth Rate of FluMist from 2014 to 2026

    • 1.3.3 Global Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval from 2014 to 2026

    • 1.3.4 Global Influenza Vaccine Market Size and Growth Rate of Anflu from 2014 to 2026

    • 1.3.5 Global Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria from 2014 to 2026

    • 1.3.6 Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4.2 Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4.3 Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4.4 Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Influenza Vaccine Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Influenza Vaccine by Major Types

    • 3.4.1 Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip

    • 3.4.2 Influenza Vaccine Market Size and Growth Rate of FluMist

    • 3.4.3 Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval

    • 3.4.4 Influenza Vaccine Market Size and Growth Rate of Anflu

    • 3.4.5 Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria

    • 3.4.6 Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin

4 Segmentation of Influenza Vaccine Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Influenza Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Influenza Vaccine in Flucelvax and Fluvirin

    • 4.4.2 Market Size and Growth Rate of Influenza Vaccine in Flucelvax and Fluvirin

    • 4.4.3 Market Size and Growth Rate of Influenza Vaccine in Flucelvax and Fluvirin

    • 4.4.4 Market Size and Growth Rate of Influenza Vaccine in Flucelvax and Fluvirin

5 Market Analysis by Major Regions

  • 5.1 Global Influenza Vaccine Production Analysis by Major Regions

  • 5.2 Global Influenza Vaccine Consumption Analysis by Major Regions

  • 5.3 Global Influenza Vaccine Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Influenza Vaccine Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Influenza Vaccine Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Influenza Vaccine Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Influenza Vaccine Production, Import, Consumption and Export Analysis

6 Product Commodity of Influenza Vaccine Market in Major Countries

  • 6.1 Top 5 Export Countries in Influenza Vaccine market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Influenza Vaccine market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Influenza Vaccine market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Influenza Vaccine market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Influenza Vaccine market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Influenza Vaccine market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Influenza Vaccine Landscape Analysis

  • 7.1 North America Influenza Vaccine Landscape Analysis by Major Types

  • 7.2 North America Influenza Vaccine Landscape Analysis by Major End-Users

  • 7.3 North America Influenza Vaccine Landscape Analysis by Major Countries

    • 7.3.1 United States Influenza Vaccine Market Volume and Growth Rate

    • 7.3.2 Canada Influenza Vaccine Market Volume and Growth Rate

    • 7.3.3 Mexico Influenza Vaccine Market Volume and Growth Rate

8 Europe Influenza Vaccine Landscape Analysis

  • 8.1 Europe Influenza Vaccine Landscape Analysis by Major Types

  • 8.2 Europe Influenza Vaccine Landscape Analysis by Major End-Users

  • 8.3 Europe Influenza Vaccine Landscape Analysis by Major Countries

    • 8.3.1 Germany Influenza Vaccine Market Volume and Growth Rate

    • 8.3.2 UK Influenza Vaccine Market Volume and Growth Rate

    • 8.3.3 France Influenza Vaccine Market Volume and Growth Rate

    • 8.3.4 Italy Influenza Vaccine Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Influenza Vaccine Market Volume and Growth Rate

    • 8.3.6 Spain Influenza Vaccine Market Volume and Growth Rate

    • 8.3.7 Belgium Influenza Vaccine Market Volume and Growth Rate

    • 8.3.8 Poland Influenza Vaccine Market Volume and Growth Rate

    • 8.3.9 Russia Influenza Vaccine Market Volume and Growth Rate

    • 8.3.10 Turkey Influenza Vaccine Market Volume and Growth Rate

9 Asia Pacific Influenza Vaccine Landscape Analysis

  • 9.1 Asia Pacific Influenza Vaccine Landscape Analysis by Major Types

  • 9.2 Asia Pacific Influenza Vaccine Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Influenza Vaccine Landscape Analysis by Major Countries

    • 9.3.1 China Influenza Vaccine Market Volume and Growth Rate

    • 9.3.2 Japan Influenza Vaccine Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Influenza Vaccine Market Volume and Growth Rate

    • 9.3.4 India Influenza Vaccine Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Influenza Vaccine Market Volume and Growth Rate

    • 9.3.6 South Korea Influenza Vaccine Market Volume and Growth Rate

10 Latin America, Middle East & Africa Influenza Vaccine Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Influenza Vaccine Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Influenza Vaccine Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Influenza Vaccine Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Influenza Vaccine Market Volume and Growth Rate

    • 10.3.2 Brazil Influenza Vaccine Market Volume and Growth Rate

    • 10.3.3 Nigeria Influenza Vaccine Market Volume and Growth Rate

    • 10.3.4 South Africa Influenza Vaccine Market Volume and Growth Rate 

    • 10.3.5 Argentina Influenza Vaccine Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 AstraZeneca

    • 11.1.1 AstraZeneca Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 CSL

    • 11.2.1 CSL Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 GlaxoSmithKline

    • 11.3.1 GlaxoSmithKline Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Sanofi

    • 11.4.1 Sanofi Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Altimmune

    • 11.5.1 Altimmune Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 BionVax

    • 11.6.1 BionVax Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 FluGen

    • 11.7.1 FluGen Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Folia Biotech

    • 11.8.1 Folia Biotech Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Genentech

    • 11.9.1 Genentech Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Green Cross

    • 11.10.1 Green Cross Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Medicago

    • 11.11.1 Medicago Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Moderna Therapeutics

    • 11.12.1 Moderna Therapeutics Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Novavax

    • 11.13.1 Novavax Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Shijiazhuang Yiling Pharmaceutical

    • 11.14.1 Shijiazhuang Yiling Pharmaceutical Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 SK Chemicals

    • 11.15.1 SK Chemicals Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 UNM Pharma

    • 11.16.1 UNM Pharma Company Profile and Recent Development

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Vaccitec

    • 11.17.1 Vaccitec Company Profile and Recent Development

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 104 Figures and 154 Tables)

  • Figure Product Picture

  • Figure Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip from 2014 to 2026

  • Figure Influenza Vaccine Market Size and Growth Rate of FluMist from 2014 to 2026

  • Figure Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval from 2014 to 2026

  • Figure Influenza Vaccine Market Size and Growth Rate of Anflu from 2014 to 2026

  • Figure Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria from 2014 to 2026

  • Figure Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • Figure Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • Figure Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • Figure Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Influenza Vaccine Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Influenza Vaccine

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Influenza Vaccine by Different Types from 2014 to 2026

  • Table Consumption Share of Influenza Vaccine by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Fluzone/Vaxigrip

  • Figure Market Size and Growth Rate of FluMist

  • Figure Market Size and Growth Rate of Fluarix and Flulaval

  • Figure Market Size and Growth Rate of Anflu

  • Figure Market Size and Growth Rate of Fluvax/Afluria

  • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Influenza Vaccine by Different End-Users from 2014 to 2026

  • Table Consumption Share of Influenza Vaccine by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

  • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

  • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

  • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

  • Table Global Influenza Vaccine Production by Major Regions

  • Table Global Influenza Vaccine Production Share by Major Regions

  • Figure Global Influenza Vaccine Production Share by Major Regions in 2014

  • Figure Global Influenza Vaccine Production Share by Major Regions in 2018

  • Figure Global Influenza Vaccine Production Share by Major Regions in 2026

  • Table Global Influenza Vaccine Consumption by Major Regions

  • Table Global Influenza Vaccine Consumption Share by Major Regions

  • Figure Global Influenza Vaccine Consumption Share by Major Regions in 2014

  • Figure Global Influenza Vaccine Consumption Share by Major Regions in 2018

  • Figure Global Influenza Vaccine Consumption Share by Major Regions in 2026

  • Table North America Influenza Vaccine Production, Import, Consumption and Export Analysis

  • Table Europe Influenza Vaccine Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Influenza Vaccine Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Influenza Vaccine Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Influenza Vaccine market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Influenza Vaccine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Influenza Vaccine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Influenza Vaccine market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Influenza Vaccine Consumption by Types from 2014 to 2026

  • Table North America Influenza Vaccine Consumption Share by Types from 2014 to 2026

  • Figure North America Influenza Vaccine Consumption Share by Types in 2014

  • Figure North America Influenza Vaccine Consumption Share by Types in 2018

  • Figure North America Influenza Vaccine Consumption Share by Types in 2026

  • Table North America Influenza Vaccine Consumption by End-Users from 2014 to 2026

  • Table North America Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure North America Influenza Vaccine Consumption Share by End-Users in 2014

  • Figure North America Influenza Vaccine Consumption Share by End-Users in 2018

  • Figure North America Influenza Vaccine Consumption Share by End-Users in 2026

  • Table North America Influenza Vaccine Consumption by Major Countries from 2014 to 2026

  • Table North America Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Influenza Vaccine Consumption Share by Major Countries in 2014

  • Figure North America Influenza Vaccine Consumption Share by Major Countries in 2018

  • Figure North America Influenza Vaccine Consumption Share by Major Countries in 2026

  • Figure United States Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Influenza Vaccine Consumption by Types from 2014 to 2026

  • Table Europe Influenza Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Europe Influenza Vaccine Consumption Share by Types in 2014

  • Figure Europe Influenza Vaccine Consumption Share by Types in 2018

  • Figure Europe Influenza Vaccine Consumption Share by Types in 2026

  • Table Europe Influenza Vaccine Consumption by End-Users from 2014 to 2026

  • Table Europe Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Influenza Vaccine Consumption Share by End-Users in 2014

  • Figure Europe Influenza Vaccine Consumption Share by End-Users in 2018

  • Figure Europe Influenza Vaccine Consumption Share by End-Users in 2026

  • Table Europe Influenza Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Europe Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Influenza Vaccine Consumption Share by Major Countries in 2014

  • Figure Europe Influenza Vaccine Consumption Share by Major Countries in 2018

  • Figure Europe Influenza Vaccine Consumption Share by Major Countries in 2026

  • Figure Germany Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure France Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Influenza Vaccine Consumption by Types from 2014 to 2026

  • Table Asia Pacific Influenza Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Influenza Vaccine Consumption Share by Types in 2014

  • Figure Asia Pacific Influenza Vaccine Consumption Share by Types in 2018

  • Figure Asia Pacific Influenza Vaccine Consumption Share by Types in 2026

  • Table Asia Pacific Influenza Vaccine Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Influenza Vaccine Consumption Share by End-Users in 2014

  • Figure Asia Pacific Influenza Vaccine Consumption Share by End-Users in 2018

  • Figure Asia Pacific Influenza Vaccine Consumption Share by End-Users in 2026

  • Table Asia Pacific Influenza Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Influenza Vaccine Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Influenza Vaccine Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Influenza Vaccine Consumption Share by Major Countries in 2026

  • Figure China Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandInfluenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure India Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Influenza Vaccine Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Influenza Vaccine Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Influenza Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Influenza Vaccine Consumption Share by Major Countries in 2026

  • Figure GCC Countries Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca

  • Table Company Profile and Development Status of CSL

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

  • Figure Sales and Growth Rate Analysis of CSL

  • Figure Revenue and Market Share Analysis of CSL

  • Table Product and Service Introduction of CSL

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline

  • Table Company Profile and Development Status of Sanofi

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

  • Figure Sales and Growth Rate Analysis of Sanofi

  • Figure Revenue and Market Share Analysis of Sanofi

  • Table Product and Service Introduction of Sanofi

  • Table Company Profile and Development Status of Altimmune

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune

  • Figure Sales and Growth Rate Analysis of Altimmune

  • Figure Revenue and Market Share Analysis of Altimmune

  • Table Product and Service Introduction of Altimmune

  • Table Company Profile and Development Status of BionVax

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BionVax

  • Figure Sales and Growth Rate Analysis of BionVax

  • Figure Revenue and Market Share Analysis of BionVax

  • Table Product and Service Introduction of BionVax

  • Table Company Profile and Development Status of FluGen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FluGen

  • Figure Sales and Growth Rate Analysis of FluGen

  • Figure Revenue and Market Share Analysis of FluGen

  • Table Product and Service Introduction of FluGen

  • Table Company Profile and Development Status of Folia Biotech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Folia Biotech

  • Figure Sales and Growth Rate Analysis of Folia Biotech

  • Figure Revenue and Market Share Analysis of Folia Biotech

  • Table Product and Service Introduction of Folia Biotech

  • Table Company Profile and Development Status of Genentech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech

  • Figure Sales and Growth Rate Analysis of Genentech

  • Figure Revenue and Market Share Analysis of Genentech

  • Table Product and Service Introduction of Genentech

  • Table Company Profile and Development Status of Green Cross

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross

  • Figure Sales and Growth Rate Analysis of Green Cross

  • Figure Revenue and Market Share Analysis of Green Cross

  • Table Product and Service Introduction of Green Cross

  • Table Company Profile and Development Status of Medicago

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicago

  • Figure Sales and Growth Rate Analysis of Medicago

  • Figure Revenue and Market Share Analysis of Medicago

  • Table Product and Service Introduction of Medicago

  • Table Company Profile and Development Status of Moderna Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

  • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

  • Figure Revenue and Market Share Analysis of Moderna Therapeutics

  • Table Product and Service Introduction of Moderna Therapeutics

  • Table Company Profile and Development Status of Novavax

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

  • Figure Sales and Growth Rate Analysis of Novavax

  • Figure Revenue and Market Share Analysis of Novavax

  • Table Product and Service Introduction of Novavax

  • Table Company Profile and Development Status of Shijiazhuang Yiling Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shijiazhuang Yiling Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Shijiazhuang Yiling Pharmaceutical

  • Figure Revenue and Market Share Analysis of Shijiazhuang Yiling Pharmaceutical

  • Table Product and Service Introduction of Shijiazhuang Yiling Pharmaceutical

  • Table Company Profile and Development Status of SK Chemicals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals

  • Figure Sales and Growth Rate Analysis of SK Chemicals

  • Figure Revenue and Market Share Analysis of SK Chemicals

  • Table Product and Service Introduction of SK Chemicals

  • Table Company Profile and Development Status of UNM Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UNM Pharma

  • Figure Sales and Growth Rate Analysis of UNM Pharma

  • Figure Revenue and Market Share Analysis of UNM Pharma

  • Table Product and Service Introduction of UNM Pharma

  • Table Company Profile and Development Status of Vaccitec

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaccitec

  • Figure Sales and Growth Rate Analysis of Vaccitec

  • Figure Revenue and Market Share Analysis of Vaccitec

  • Table Product and Service Introduction of Vaccitec


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top